Komal Jhaveri

The Genomic Landscape of Endocrine-Resistant Advanced Breast Cancers

Pedram Razavi, Matthew T. Chang, Guotai Xu et al. · Cancer Cell · 2018 · 956 citations · Full text

Breast Oncology, Genomic Landscape, Cancer Genomics +3

HER kinase inhibition in patients with HER2- and HER3-mutant cancers

David M. Hyman, Sarina A. Piha‐Paul, Helen Won et al. · Nature · 2018 · 752 citations · Full text

Tumor Biology, Oncology, Medicine +8

Capivasertib in Hormone Receptor–Positive Advanced Breast Cancer

Nicholas C. Turner, Mafalda Oliveira, Sacha J. Howell et al. · New England Journal of Medicine · 2023 · 600 citations · Full text

Overall survival with sacituzumab govitecan in hormone receptor-positive and human epidermal growth factor receptor 2-negative metastatic breast cancer (TROPiCS-02): a randomised, open-label, multicentre, phase 3 trial

Hope S. Rugo, Aditya Bardia, Frederik Marmé et al. · The Lancet · 2023 · 363 citations · Full text

Double <i>PIK3CA</i> mutations in cis increase oncogenicity and sensitivity to PI3Kα inhibitors

Neil Vasan, Pedram Razavi, Jared L. Johnson et al. · Science · 2019 · 281 citations · Full text